-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes United Therapeutics at Buy, Announces Price Target of $660

Benzinga·11/09/2026 11:19:23
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield assumes United Therapeutics (NASDAQ:UTHR) with a Buy rating and announces Price Target of $660.